TSSK4
Basic information
Region (hg38): 14:24205696-24208362
Previous symbols: [ "C14orf20", "STK22E" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TSSK4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 21 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 21 | 1 | 0 |
Variants in TSSK4
This is a list of pathogenic ClinVar variants found in the TSSK4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-24205979-T-G | not specified | Uncertain significance (May 11, 2022) | ||
14-24206002-G-T | not specified | Uncertain significance (Aug 19, 2024) | ||
14-24206021-A-G | not specified | Uncertain significance (Dec 20, 2023) | ||
14-24206036-C-T | not specified | Uncertain significance (Feb 01, 2023) | ||
14-24206525-G-A | not specified | Uncertain significance (Dec 30, 2024) | ||
14-24206533-T-A | not specified | Uncertain significance (Sep 16, 2021) | ||
14-24206552-G-A | not specified | Likely benign (Sep 24, 2024) | ||
14-24206591-A-G | not specified | Uncertain significance (Aug 16, 2021) | ||
14-24206722-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
14-24207162-A-C | not specified | Uncertain significance (Feb 22, 2023) | ||
14-24207175-A-C | not specified | Uncertain significance (Aug 20, 2024) | ||
14-24207193-A-G | not specified | Uncertain significance (Nov 26, 2024) | ||
14-24207261-C-G | not specified | Uncertain significance (Oct 02, 2023) | ||
14-24207329-G-C | not specified | Uncertain significance (Oct 11, 2024) | ||
14-24207363-T-G | not specified | Uncertain significance (Aug 08, 2022) | ||
14-24207364-C-G | not specified | Uncertain significance (Apr 20, 2024) | ||
14-24207370-C-T | not specified | Uncertain significance (Jul 26, 2024) | ||
14-24207394-A-G | not specified | Uncertain significance (Mar 15, 2024) | ||
14-24207985-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
14-24207986-G-A | not specified | Likely benign (Jan 23, 2025) | ||
14-24208031-C-T | not specified | Uncertain significance (Sep 14, 2022) | ||
14-24208043-A-G | not specified | Uncertain significance (Nov 21, 2023) | ||
14-24208057-C-G | not specified | Uncertain significance (Aug 26, 2024) | ||
14-24208139-C-T | not specified | Uncertain significance (Mar 29, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TSSK4 | protein_coding | protein_coding | ENST00000339917 | 4 | 2666 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.46e-9 | 0.127 | 125565 | 1 | 182 | 125748 | 0.000728 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.06 | 148 | 189 | 0.782 | 0.0000102 | 2211 |
Missense in Polyphen | 60 | 81.157 | 0.73931 | 999 | ||
Synonymous | 0.954 | 63 | 73.4 | 0.858 | 0.00000378 | 670 |
Loss of Function | 0.131 | 13 | 13.5 | 0.962 | 7.45e-7 | 155 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00187 | 0.00187 |
Ashkenazi Jewish | 0.000397 | 0.000397 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.000558 | 0.000416 |
European (Non-Finnish) | 0.000572 | 0.000571 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000980 | 0.000980 |
Other | 0.00179 | 0.00179 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine kinase which is involved in male germ cell development and in mature sperm function (By similarity). May be involved in the Cre/Creb signaling pathway (By similarity). Phosphorylates CREB1 on 'Ser-133' in vitro and can stimulate Cre/Creb pathway in cells (PubMed:15964553). Phosphorylates CREM on 'Ser-116' in vitro (By similarity). Phosphorylates ODF2 on 'Ser-95' (By similarity). {ECO:0000250|UniProtKB:Q9D411, ECO:0000269|PubMed:15964553}.;
Recessive Scores
- pRec
- 0.0929
Intolerance Scores
- loftool
- 0.912
- rvis_EVS
- 0.44
- rvis_percentile_EVS
- 77.7
Haploinsufficiency Scores
- pHI
- 0.218
- hipred
- N
- hipred_score
- 0.147
- ghis
- 0.428
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.218
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tssk4
- Phenotype
- cellular phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- protein phosphorylation;multicellular organism development;spermatogenesis;cell differentiation;positive regulation of CREB transcription factor activity;intracellular signal transduction
- Cellular component
- acrosomal vesicle;nucleus;cytoplasm;motile cilium
- Molecular function
- magnesium ion binding;protein serine/threonine kinase activity;protein binding;ATP binding